Catch up on the 9 FDA drug approvals most relevant to primary care, including new options for HIV-1 infection, narcolepsy, diabetes, pain management, and more.
News|Slideshows|May 9, 2024
American’s Views on Mental Health Care: Survey Finds Most Perceive Gaps
Author(s)Sydney Jennings
From top barriers in seeking treatment to how well mental health issues are identified and treated, find out what US adults really think about the mental health care system.
Advertisement
A recent survey conducted by Gallup and West Health assessed American’s opinions on various aspects of the nation’s mental health care system, including how mental health issues are treated compared to physical issues, factors that may prevent them from seeking treatment, effectiveness of different forms of treatments, and more. The
Scroll through the slides below for key findings.
Advertisement
Related to this article
Asundexian reduced relative ischemic stroke risk by 26% alongside antiplatelet therapy, with bleeding concerns in older adults.
Abbott's investigational device achieved 96.3% complete left atrial appendage closure by echocardiography, with a 1.8% ischemic stroke rate at 1 year.
Christoph Correll, MD, discusses the new once-monthly olanzapine injection for schizophrenia, including clinical efficacy, metabolic risks, and patient selection.
Hormone Therapy Linked to More Frequent Migraines, but Not Greater Severity, in Postmenopausal Women
TMS 2026: A meta-analysis of 5 studies found hormone therapy linked to more frequent migraine attacks and migraine days, but not greater severity or analgesic use.
FDA has granted IDE approval for the STROKE-REWIRE pivotal trial evaluating NeuWire Medical's neurostimulation device for chronic ischemic stroke recovery.
Advertisement
Advertisement
Trending on Patient Care Online
1
American Cancer Society Updates Prostate Cancer Screening Guidelines
2
FDA Approves Asundexian for Stroke Prevention After Ischemic Stroke or TIA
3
Yoga-Based Cardiac Rehab Improves Quality of Life in Heart Failure Trial
4
Retatrutide Phase 3 Trials Report Reduced Knee Osteoarthritis Pain
5